Hydrocarbon stapling can restore bioactive a-helical structure to natural peptides, yielding research tools and prototype therapeutics to dissect and target protein interactions. Here we explore the capacity of peptide stapling to generate high-fidelity, protease-resistant mimics of antigenic structures for vaccine development. HIV-1 has been refractory to vaccine technologies thus far, although select human antibodies can broadly neutralize HIV-1 by targeting sequences of the gp41 juxtamembrane fusion apparatus. To develop candidate HIV-1 immunogens, we generated and characterized stabilized a-helices of the membraneproximal external region (SAH-MPER) of gp41. SAH-MPER peptides were remarkably protease resistant and bound to the broadly neutralizing 4E10 and 10E8 antibodies with high affinity, recapitulating the structure of the MPER epitope when differentially engaged by the two anti-HIV Fabs. Thus, stapled peptides may provide a new opportunity to develop chemically stabilized antigens for vaccination. npg
a r t i c l e s Antibodies neutralize pathogens by recognizing discrete and distinguishing peptidic motifs. By presenting primary, secondary and tertiary structures to the host immune system, vaccines have revolutionized the capacity to prevent human infection. Nevertheless, some targets, such as HIV type 1 (HIV-1), have been refractory to vaccine development. To achieve sterilizing HIV-1 immunity, an effective vaccine must elicit broadly neutralizing antibodies that intercept the virus before immune-cell penetrance 1 . Upon interaction of the HIV-1 envelope (Env) glycoprotein with host receptors, the Env viral fusion protein undergoes a series of conformational changes that are essential to penetrating the plasma membrane and fusing the viral and host membranes. Three copies of the HIV-1 envelope glycoproteins gp120 and gp41, which are noncovalently associated, form the Env trimer 2 . Once gp120 binds to CD4 (ref. 3 ) and co-receptor 4 on the host's cell membrane, gp41 transforms from its metastable native state into a fusogenic six-helix bundle 5, 6 that conjoins viral and host-cell membranes, enabling viral-particle uptake. The regions of gp41 involved in this structural reorganization are the N-terminal heptad repeat (HR1) found just downstream of the fusion peptide and the C-terminal heptad repeat (HR2), which is close to the transmembrane region. The membrane-proximal external region 7 Structural studies have identified critical motifs in gp41 that engage broadly neutralizing antibodies [10] [11] [12] [13] [14] [15] [16] [17] . The crystal structure of 4E10 Fab in complex with a 13-residue portion of the MPER (amino acids 671-683) previously demonstrated that this peptide epitope adopts an α-helical conformation. Residues W672-D674 are configured as a short 3 10 helix that directs the N terminus out of the binding site 18 , and the interaction surface is composed of key residues W672, F673, I675 and T676 (ref. 12 ). Analysis of a longer 22-residue MPER peptide (amino acids 662-683) in a lipid context, by a combination of NMR and EPR spectroscopy, revealed a unique L-shaped structure reflecting a bipartite α-helix segmented by a kink 17 . The 10E8 antibody also recognizes an extended MPER peptide (amino acids 656-683) in a helixkink-helix conformation, with each α-helix oriented 100° relative to the other 10 . In contrast, 2F5 binds to its target MPER sequences in a largely extended conformation with a central β-turn 16 . Importantly, upstream α-helical HR2 sequences, the transmembrane domain, the trimeric nature of the viral spike and the plasma membrane itself may provide an important structural context that constrains and thereby helps define the neutralization-competent antigenic structure(s) of the MPER 19 .
Diverse approaches have been applied to display the MPER domain for vaccine development, including computational design of epitope scaffolds [20] [21] [22] [23] [24] , MPER grafting 25 , use of chimeric viruses 26 and immunization with cells expressing the gp41 postfusion complex 27 . Despite these efforts, non-neutralizing responses are the norm [23] [24] [25] . The conformations and orientations of MPER sequences displayed on the surface of nanoparticles 28 , rhinovirus 26 or human cells 27 may be distinct from the pathologic epitope in vivo or may elicit off-target immune responses to the scaffold itself. Peptidic approaches to MPER mimicry have also been unsuccessful to date, potentially owing to limitations in a r t i c l e s peptide size, stability and delivery, as documented for peptide vaccine studies in general [29] [30] [31] .
Introduction of noncovalent or covalent constraints to stabilize variably structured MPER sequences of different length has enhanced binding to select broadly neutralizing antibodies but has not necessarily elicited a broadly neutralizing response 32, 33 . These data suggest that perhaps an MPER motif of optimal size or structure in the appropriate context (such as the membrane environment) was not reproduced, or structural integrity was not maintained in vivo because of proteolysis. We have found for structured therapeutic peptides that noncovalently constrained constructs are rapidly proteolyzed 34 , and covalently constrained peptides bearing labile cross-links (for example, disulfides and amides) are also vulnerable. Indeed, the structural lability of the Env trimer itself was recently shown to be a critical factor in eliciting non-neutralizing anti-HIV-1 antibodies 35 . Although broadly neutralizing antibodies that target the HIV-1 envelope are among the most protective for preventing HIV-1 transmission, the requisite set of immunogens to appropriately guide an effective immune response has been elusive to date 36 .
Two of the historically most broadly neutralizing monoclonal antibodies, 2F5 and 4E10, have been proposed to cross-react with selfantigens [37] [38] [39] [40] [41] [42] , thus raising the specter of autoreactivity as an unwanted consequence of a potential MPER-based vaccine. To preclude autoreactivity, a normal immune response may not permit the emergence of MPER-directed neutralizing antibodies. Such concerns, however, have been mitigated by the recent discovery of 10E8, a potent and broadly neutralizing antibody that also engages a helical MPER but does so without autoantigen recognition 10 , thus providing a compelling basis for revisiting an MPER-based vaccine strategy. Interestingly, a recent follow-up study demonstrated that 10E8 retains weak affinity for lipid membranes and suggested a functional role for apical residues of its complementarity-determining region (CDR)-H3 in membrane binding and viral neutralization 43 , as also observed for 2F5 (ref. 21) and 4E10 (ref. 20) . When taken together, these studies indicate that effective HIV-1 neutralization by MPER-specific antibodies mechanistically involves interactions with viral lipids 16, 20, 21, 43 , yet structural delineation of the lipid-binding site(s) on MPER antibodies is lacking. Ultimately, structured MPER peptides presented in a lipid context or MPER-based antigens designed to contain lipid-recognition moieties may be ideally suited for vaccine development 43 .
Motivated by fresh insights into the conformation of MPER epitopes in the membrane context 17 and in complex with potent and broadly neutralizing antibodies 10 , we sought to design SAH-MPERs that reflect the full-length domain and reinforce both helical components of the helix-kink-helix structure. Our peptide-stapling method has yielded remarkably protease-resistant α-helical peptides 34 , transforming tool reagents into prototype therapeutics with in vivo efficacy [44] [45] [46] [47] . Importantly, the all-hydrocarbon constraint is itself protease resistant, thus differentiating this chemical approach from prior peptidestabilization efforts and potentially rendering it well suited for the development of structured antigens in general. Here, we demonstrate that SAH-MPER peptides retain high-affinity binding activity toward two broadly neutralizing anti-HIV-1 antibodies, exhibit markedly enhanced protease resistance and recapitulate the critical antibodyrecognition motif, as evidenced by crystal structures of the corresponding 4E10 and 10E8 complexes.
RESULTS

Design and 4E10-binding activity of SAH-MPER peptides
To generate candidate HIV-1 immunogens with neutralizationcompetent structure, we sought to replicate the bipartite α-helical conformation of the full-length MPER domain ( Fig. 1a) . To independently stabilize the respective N-terminal (662-671) and C-terminal (675-683) helices, which are separated by a flexible hinge region (672-674), we performed staple scans in each region of the MPER peptide. We substituted pairs of (S)-2-(((9H-fluoren-9-yl)methoxy) carbonylamino)-2-methyl-hept-6-enoic acids (abbreviated as S5 residues) at the i and i + 4 positions within the N-terminal region and performed ruthenium-catalyzed ring-closing metathesis (RCM) to generate six single-stapled peptides, termed SAH-MPER (662-683) A-F ( Fig. 1b and Supplementary Table 1 ). Within the C-terminal region, we made i, i + 4 and i, i + 3 substitutions in order to accommodate αor 3 10 -helical conformation, generating 13 single-stapled peptides, termed SAH-MPER (662-683) G-L (i, i + 4) and M-S (i, i + 3) ( Fig. 1c) . Of note, i, i + 3 hydrocarbon stapling of S5 residues required a prolonged reaction time at elevated temperature to achieve yields similar to those of the traditional i, i + 4 reaction, which is consistent with pentane interference from the resultant cross-link that drapes over the N-terminal α-methyl group 48 .
We compared the binding activity of 4E10 antibody across our diverse hydrocarbon-stapled peptides by competitive enzyme-linked immunosorbent assay (ELISA), pitting the unmodified MPER peptide (amino acids 662-683) against fluorescein isothiocyanate (FITC)-labeled competitor constructs. Whereas the affinity-driving contacts of 4E10 are on the C-terminal half of the MPER peptide 12 , we chose to incorporate N-terminal MPER sequence into our designs to maximize their potential immunogenic surface. Among the N-terminal i, i + 4 stapled constructs, all but the most C-terminal F staple was tolerated, results consistent with this N-terminal portion of the MPER domain lying outside the core 4E10-binding region and with staple encroachment on the kink region being disfavored ( Fig. 1b) . Among the C-terminal i, i + 4 and i, i + 3 stapled constructs, only two constructs showed 4E10 binding activity. In each case, the favorable staple localized to the noninteracting helical surface and centered around the highly conserved L679-W680 motif. The C-terminal i, i + 4 staple K conferred a three-fold improvement in 4E10 binding activity, whereas the i, i + 3 staple Q yielded a 60-fold enhancement (Fig. 1c) . The exquisite sensitivity of 4E10 binding activity to staple location emphasizes the importance of staple scanning to identify insertion points that balance structural reinforcement and preservation of key residues and binding interfaces.
To reinforce both helical motifs that flank the kink and to maximize protease resistance 34 , we sought to generate double-stapled peptides, combining the C-terminal i, i + 3 Q staple with those N-terminal staple positions that yielded similar or improved 4E10 binding activity (A-E). However, the designed (i, i + 4), (i, i + 3) MPER constructs either failed to metathesize or resulted in minimal yield even after prolonged reaction at elevated temperatures, which is consistent with the requirement for relatively extreme conditions to accomplish single i, i + 3 stapling with S5. These results compelled us to determine which alternative non-natural olefin-bearing amino acids would enable i, i + 3 stapling to proceed as smoothly as single and double i, i + 4 stapling with S5 (ref. 34 ).
Optimization of i, i + 3 stapling for SAH-MPER design
We tested the reactivity of an alternative stapling amino acid pair in order to optimize i, i + 3 stapling for SAH-MPER synthesis. For a simplified peptide template, we used the previously described 4E10-binding epitope that corresponds to the C-terminal half of the MPER domain, with an appended trio of lysines to enhance solubility 18 (hereafter referred to as MPER (671-683KKK) ). We installed S5 residues at positions 678 and 681 and exposed the resin-bound peptide to ruthenium-catalyzed RCM for 2 h at room temperature, with no observed metathesis (data not shown). Then we escalated npg a r t i c l e s each other. Therefore, we installed an S5 residue at position 681 and an R3 residue, (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2methyl-pent-4-enoic acid, at position 678. Remarkably, we achieved almost complete conversion of the starting material into metathesized product with only 2 h incubation at room temperature, results matching the synthetic efficiency of i, i + 4 stapling with two S5 residues ( Fig. 2b) . In accordance with the enhanced 4E10 binding affinity derived from S5-S5 stapling at the Q position of the full-length MPER peptide, R3-S5 stapling of the 671-683KKK construct at position Q (designated q to reflect the alternate staple composition) resulted in five-fold improvement in competitive binding activity compared to that of the unmodified MPER (671-683KKK) peptide ( Fig. 2c) .
Crystal structure of a stapled MPER peptide bound to 4E10
We determined the crystal structure of the 4E10 Fab-SAH-MPER (671-683KKK) (q) complex at 2.9-Å resolution with one Fab-peptide complex per asymmetric unit ( Fig. 3a and Table 1 ). With the exception of the C-terminal lysine side chains, all main chains and side chains of the stapled peptide residues could be modeled into the electron density map (Fig. 3b) . The relatively weak electron density for the region of the six-atom carbon staple, which replaced the side chains of W678 and Y681, could not distinguish between Z and E olefin isomers (or exclude the possibility of a stereoisomeric mixture) and was modeled in a Z conformation in this 2.9-Å structure. Density appeared for most of the main chain of the flexible CDR-H3 loop (residues 99-100D, except W100 (H) and G100A (H) , where the (H) superscript stands for heavy chain) ( Supplementary Fig. 1a ) 18 . The complexes of 4E10 Fab with SAH-MPER (671-683KKK) (q) and the original (unmodified) 4E10epitope peptide (PDB 2FX7) 18 superpose with an r.m.s deviation of 0.73 Å for the Cα atoms and are overall very similar ( Supplementary  Fig. 1b ). Superposing the peptide regions revealed essentially identical Fab-binding interfaces, highlighting that the q staple reinforces the reaction conditions to an 18-h incubation at 84 °C (reflux in dichloroethane), finding that only 20% conversion was achieved, as demonstrated by an overlay of the high-performance liquid chromatography (HPLC) traces of starting material and reaction product ( Fig. 2a) . We reasoned that shortening the alkenyl side chain of one of the amino acids from five to three carbons and inverting the more N-terminal stereocenter would mitigate steric hindrance and orient the olefins toward npg a r t i c l e s the natural peptide-bound structure (Fig. 3c) . Like the side chains of W678 and Y681, the six-carbon staple that replaces these natural residues does not contact the antibody, owing to its location on the solvent-exposed face of the helical peptide. Thus, hydrocarbon stapling effectively recapitulates the native antigenic epitope, with the structurally reinforcing staple positioned away from, and thereby not perturbing, the critical binding interface.
Identification of a phosphate-binding site on 4E10
The MPER-specific antibodies 2F5 and 4E10 can also bind several phospholipid antigens 39 . The initial difference Fourier electron density map of our 4E10 Fab-SAH-MPER (671-683KKK) (q) complex revealed roughly spherical electron density of approximately 7σ located between S28H and S30H of the CDR-H1 loop (Fig. 4a,b) . Both phosphate and chloride ions were present in the crystallization conditions (based on motherliquor conditions that contained sodium and potassium phosphate (0.1 M) and sodium chloride (0.2 M)). When a chloride ion was refined into the extra density, residual positive electron density still remained in F o − F c maps. Thus, we interpreted the spherical density as a phosphate ion, which fits the density with a real-space correlation coefficient of 0.96. Although the B value for the phosphate ion is high (~110 Å 2 , Table 1 ) compared to that of the overall protein, it is nevertheless close to that of neighboring CDR-H1 residues (~90 Å 2 for S28 (H) , 74 Å 2 for F29 (H) and 83 Å 2 for S30 (H) ; Fig. 4b ).
Elevated isotropic B values were also observed for these CDR-H1 npg a r t i c l e s loop residues in the previous 4E10 Fab-native MPER (671-683KKK) (PDB 2FX7) 18 structure in comparison to mean isotropic and Wilson B values at the corresponding resolution 18 , thus suggesting increased structural flexibility. The superposition of the phosphate-incorporated site with the same region in the 4E10 Fab-native MPER (671-683KKK) complex (PDB 2FX7) 18 , which was crystallized from phosphate-free buffer, demonstrates torqueing of backbone amides and reorientation of the S28 (H) hydroxyl toward the phosphate ion to promote favorable hydrogen-bond interactions in the 4E10 Fab-SAH-MPER (671-683KKK) (q) structure (Fig. 4c) . The presence of a phosphate-binding site in the CDR-H1 loop region of 4E10 is consistent with antibody binding to anionic lipids at the membrane surface. Indeed, the orientation of SAH-MPER (671-683KKK) (q) within the antigenbinding site positions the C-terminal residues 684-686, which are replaced here by lysines and would compose the start of the gp41 transmembrane segment, immediately adjacent to the identified phosphate-binding site (Fig. 4a) .
To our knowledge, we have detected this phosphate-binding site in the 4E10 combining region for the first time, because a PDB search of all available 4E10 structures did not reveal phosphate as a buffer component of prior crystallization conditions. A recent crystal structure of the 4E10 variable region (Fv) in a ligand-free form 49 shows sulfate ions near the CDR-H1 loop, but none of the ions are in the same position as that observed here for the phosphate. In fact, a glycerol molecule is present in this position in one of the four Fv molecules in the asymmetric unit. Whereas sulfate and phosphate ions are similar, and can occupy the same binding site in a protein, the peptide-free structure of 4E10 (ref. 49 ) has its CDR-H1 and CDR-H3 loops drastically perturbed in comparison to the peptide-bound form 18 . In the ligand-free structure, the CDR-H3 occupies the peptide-binding site but is also involved in extensive packing interactions with symmetry-related 
Crystal structure of 4E10 and a SAH-MPER phosphopeptide
To probe the potential role of phosphate engagement as a 4E10 binding determinant at the membrane, we generated a modified SAH-MPER (671-683KKK) (q) peptide containing a tethered phosphate moiety. From the predicted 5.5-Å distance between the K683 side chain amine and phosphate group (Fig. 4a) , we modeled in a phosphoserine (pSer) group and determined that it could be appropriately linked to the peptide backbone by a diaminobutanoic acid-glycine (Dab-Gly) spacer at position 683 ( Fig. 5a) . We then synthesized SAH-MPER (671-683KKK) (q) containing the Dab-Gly-phosphoserine (pSer) tether at the 683 position or, as a negative control, at the 685 position, which would orient pSer away from the binding interface (Supplementary Fig. 2a ). Competitive 4E10 binding analysis revealed a slight improvement in binding affinity upon incorporation of a phosphate moiety at position 683, whereas installing the equivalent derivatization at position 685 actually reduced binding activity (Supplementary Fig. 2b) .
To confirm that the installed phosphate moiety at position 683 interacted with the defined phosphate-binding site at the 4E10 interface, we undertook structural analysis of the 4E10 Fab bound to phosphatederivatized SAH-MPER (671-683KKK) (q)pSer peptide containing the Dab-Gly spacer. We determined the structure of the complex at 2.68-Å resolution from a crystal grown in phosphate-free mother liquor (Fig. 5b) . The initial difference Fourier map shows unambiguous positive electron density for the covalently linked staple, which fit the electron density with a real-space correlation coefficient of 0.98 and an isotropic B value of 49 Å 2 , in good agreement with the Wilson plot and mean isotropic B values (Table 1 and Supplementary Fig. 3a,b) .
In contrast, the initial positive F o -F c (3σ level) and the 2F o -F c (1σ level) maps show incomplete electron density for the central portion of the Dab-Gly linker (Supplementary Fig. 4a ). However, the final 2F o -F c density of the Dab linker ( Supplementary Fig. 4b ) improved after refinement as compared to the density for the SAH-MPER (671-683KKK) (q) K683 (Fig. 4b) or with the density for the same lysine in the 1.76-Å structure of native MPER (671-683KKK) in complex with 4E10 (PDB 2FX7) 18 , where we observed density for only the main chain. With the exception of two atoms (OZ1 and N6), all of the atoms of the Dab-Gly-pSer are located inside the 2F o -F c electron density map at the 0.8σ level (Supplementary Fig. 4c) . Therefore, the strong density (5σ level in the initial F o -F c map) for the phosphate moiety and the improved density of the Dab linker, combined with the absence of phosphate in the mother liquor, indicate that the Dab-Gly-pSer tether at position 683 extends into the phosphatebinding site (Fig. 5b,c and Supplementary Fig. 4d ). However, for the linker atoms that connect the peptide backbone to the phosphate moiety, we observed reduced density for the eight-atom linker and a high isotropic B value of approximately 112 Å 2 (~105 Å 2 for the whole Dab-Gly-pSer moiety; Table 1 ), indicative of its flexibility. The 4E10 Fab complexes with SAH-MPER (671-683KKK) (q)pSer and SAH-MPER (671-683KKK) (q) are otherwise very similar, with only 0.23-Å r.m.s. deviation (all Cα atoms) for the Fab and 0.17-Å r.m.s. deviation (all Cα atoms) for the corresponding peptides ( Supplementary  Fig. 1b and Supplementary Fig. 3c ).
Potency and stability of double-stapled MPER epitopes
The small size of the MPER (671-683KKK) template and its limited sites for installing staples, along with its rapid proteolysis ( Supplementary  Fig. 5 ), continued to render (i, i + 4), (i, i + 3) double-stapling of the extended MPER peptide the most compelling design to maximize immunogenic surface, reinforce neutralization-competent structure and ensure protease resistance. Applying R3-S5 (i, i + 3) and S5-S5 (i, i + 4) stapling, we successfully generated all five double-stapled constructs with the standard 4-h, room-temperature metathesis conditions (Fig. 6a) . Competitive 4E10 binding analysis demonstrated halfmaximal inhibitory concentration (IC 50 npg a r t i c l e s (132 nM versus 91 nM, respectively), in which the 4E10-binding determinant (amino acids 671-683) is optimally stabilized by an i, i + 3 staple at positions 678 and 681 (Fig. 6a) .
To interrogate the relative protease resistance of double-stapled SAH-MPER constructs, we subjected peptides to chymotrypsin proteolysis and monitored the time-dependent degradation of full-length SAH-MPER by HPLC-MS. Because the double-stapled SAH-MPER (662-683) constructs ionized poorly upon MS analysis, we also synthesized the library of constructs with C-terminal KKK tails; this increased ionization potential and facilitated detection of a greater breadth of fragment ions. As observed for the corresponding unmodified and q-stapled MPER (671-683KKK) constructs (Supplementary Fig. 5) , the unmodified and q-stapled full-length MPER (662-683KKK) peptides showed similar rapid-proteolysis profiles (Fig. 6b) . In contrast, the introduction of double staples into the MPER (662-683KKK) sequence prolonged the proteolytic half-life by approximately 10-to 90-fold compared to that of the corresponding unstapled construct (Fig. 6b) . Of the eight chymotrypsin proteolysis sites observed for the unmodified peptide, the most stable doublestapled SAH-MPERs eliminated the capacity of chymotrypsin to cleave all but one of them ( Fig. 6c and Supplementary Fig. 6) . Indeed, those chymotrypsin sites flanked by staples or located immediately adjacent to staples were completely shielded from proteolysis ( Supplementary  Fig. 6) . Thus, at the expense of only a minor decrease in binding activity relative to the single-stapled SAH-MPER (662-683) (q) construct (1.4-fold), the double-stapled SAH-MPER (662-683) (D,q) peptide, for example, achieves a 140-fold increase in chymotrypsin resistance. Although here we initially used 4E10 binding activity as a guide for candidate immunogen design, it is important to note that the variety of MPER-specific neutralizing antibodies identified to date recognize a spectrum of peptide templates and conformations. Thus, in addition to the 4E10-optimized double-stapled MPER peptides (Fig. 6a) , constructs that do not engage 4E10 (Fig. 1b,c) could potentially represent a library of alternatively structured yet highly stable MPERs for immunization.
Engagement of double-stapled MPER peptides by 10E8
The recent discovery of the 10E8 broadly neutralizing HIV-1 antibody 10 provided a unique opportunity to explore the binding interactions between our double-stapled SAH-MPERs and a different anti-MPER Fab that recognizes a helically structured MPER. We performed a 10E8 competitive ELISA binding assay analogous to that described above for 4E10 and again identified a series of compounds with nanomolar Fab-binding activity, including SAH-MPER (662-683) (A,q), SAH-MPER (662-683) (B,q) and SAH-MPER (662-683) (E,q) ( Fig. 7a) . Notably, SAH-MPER (662-683) (C,q) and SAH-MPER (662-683) (D,q), which bound to 4E10 Fab in the same nanomolar range as the other constructs ( Fig. 6a) , showed no binding activity to 10E8 Fab (Fig. 7a) . These data are consistent with binding interactions between 10E8 and residues that localize to the N-terminal portion of the MPER epitope 10 , such as S668 and L669, which are replaced by stapling amino acids in the (C,q)-and (D,q)-stapled MPER peptides. Although MPER residue W670 also contacts 10E8, replacement of this residue in SAH-MPER (662-683) (E,q) by a staple spanning the W666-W670 positions preserved high-affinity 10E8 interaction. Thus, whereas 4E10 Fab sensed no differences in N-terminal staple position, due to Fab engagement of the C-terminal portion of the MPER domain only, the 10E8 Fab was more discriminating in the upstream region that included N-terminal residues of the MPER domain.
To determine whether hydrocarbon double-stapling maintained the 10E8-bound conformation of the MPER domain, we determined the crystal structure of the 10E8 Fab in complex with SAH-MPER (662-683KKK) (B,q) ( Fig. 7b) . Crystals of the complex diffracted to 4.15-Å resolution ( Table 1) , and we solved the structure with molecular replacement and refined it to R work /R free of 22.5%/28.1%. Two complexes were present in the asymmetric unit, with their corresponding peptides displaying a Cα r.m.s. deviation of 0.3 Å across gp41 residues 670-683. We observed electron density around the C-terminal portion of the peptide, corresponding to gp41 residues S668-K683 for chain P (L669-K683 for chain C), which appeared to only partially cover the staple between residue positions 678 and 681 (Supplementary Fig. 7a ). a r t i c l e s
The region upstream of chain-P residue S668 (or chain-C residue L669) that included the staple between positions 663 and 667 was disordered and could not be built. Nevertheless, the distinctive kink and adjacent N-terminal residues that distinguish 10E8 from 4E10 interactions with the MPER domain are visualized and recapitulated in the 10E8 Fab-SAH-MPER (662-683KKK) (B,q) complex (Fig. 7b) .
Overall, the structure revealed that the staple between residue positions 678 and 681 largely reinforced the helical conformation of the C-terminal portion of the MPER peptide, as observed in the structure of 10E8 bound to the native gp41 MPER 10 . We observed the highest degree of structural homology between the 10E8-bound stapled and unmodified peptides between residues 670 and 683, thus yielding Cα and all-atom r.m.s. deviations of 0.6 and 1.8 Å, respectively ( Supplementary Fig. 7b and Supplementary Table 2) . Comparison of the contact interfaces between 10E8 and the stapled and unmodified gp41 MPER peptides also revealed a high degree of similarity, with many of the same residues mediating the interactions between them ( Supplementary Table 3 ). An interfacial surface area of 633 Å 2 was buried on the SAH-MPER (662-683KKK) (B,q) peptide, and 713 Å 2 was buried on the antibody. The heavy chain of 10E8 accounted for a majority of the interactions with the double-stapled peptide, representing 92% of the interface, in agreement with the interactions observed between the 10E8 heavy chain and the native gp41 MPER peptide. Interactions between the light chain of 10E8 and the doublestapled peptide also closely mimicked the interactions observed with the native gp41 MPER peptide ( Supplementary Table 3 ). Finally, structural superposition of the 10E8 Fab-SAH-MPER (662-683KKK) (B,q) and 4E10 Fab-SAH-MPER (671-683KKK) (q) complexes highlights the capacity of hydrocarbon-stapled antigens bearing the 671-683 motif to be differentially engaged by two distinct Fabs, each with potent and broadly neutralizing anti-HIV-1 activity (Fig. 7c) 10, 12 .
DISCUSSION
The development of a safe and effective HIV-1 vaccine represents one of the most formidable scientific challenges of our time and remains the potential game-changer for curbing the global HIV-1 epidemic. The HIV-1 envelope glycoprotein represents the main target for a humoral immune response, yet the emergence of broadly neutralizing antibodies during natural infection occurs only after one or more years of infection, owing to a series of viral immune-evasion maneuvers [50] [51] [52] . Underlying the many 'faces' of the HIV-1 envelope are critical functional intermediates whose structures, although shielded or only transiently exposed, provide a possible blueprint for antigen design. One such motif is the MPER domain, which is the physiologic target for a few broadly neutralizing antibodies. The structures of these antibody-MPER complexes, in addition to their non-neutralizing counterparts, have provided tremendous insight into exactly what three-dimensional peptide-encoded configuration may be required to guide an effective anti-HIV-1 immune response 53, 54 . How to recapitulate and then stabilize the correct essential structure(s) in order to create a relatively homogeneous candidate immunogen capable of eliciting a safe, broad and effective immune response has remained elusive.
The helical structure of the MPER domain when bound to distinct broadly neutralizing antibodies, such as 4E10 (ref. 9) and the recently identified 10E8 (10), suggests that structurally constrained peptides may provide a highly desirable template for candidate immunogen design. Seminal work in this area has led to both the identification of key residues for 4E10 engagement of a minimal essential helical MPER motif 11 and the demonstration that peptide constraint through the installation of thioether, lactam or triazole cross-links, or helixpromoting non-natural amino acids, could reinforce its structure and increase antibody binding affinity 18, 33, 55 . Structural analysis of the full-length MPER domain in a lipid context previously revealed a helix-kink-helix conformation, with α-helicity extending to the N terminus just after a bend induced at F673 (ref. 17) . We viewed this bipartite structure as an ideal opportunity to increase the immunogenic surface compared to that of the minimal 4E10-binding epitope (671-683) by reinforcing both helical segments through installation of double constraints. We chose the all-hydrocarbon cross-link afforded by olefin metathesis of installed non-natural amino acids bearing olefin tethers 56 because of the unique proteolytic stability conferred and the protease resistance of the hydrocarbon staple itself 34 . Guided by competitive 4E10 binding activity, we determined that antibody engagement of the C-terminal region of the MPER domain is exquisitely sensitive to the site of staple insertion. Indeed, a single i, i + 3 staple flanking the LW (679-680) sequence, previously shown to be critical for antibody interaction, yielded up to 60-fold enhancement in competitive 4E10 binding activity compared to the unmodified MPER peptide (Figs. 1c and 6a) . The 10E8 antibody engages both N-and C-terminal regions of the MPER domain and, in contrast to the 4E10 Fab, 10E8 was sensitive to the positioning of the N-terminal staple. These structure-activity relationship data highlight the capacity of staple scanning to uncover optimal sites for staple incorporation and antigenic structure stabilization. npg a r t i c l e s Our i, i + 3 stapling efforts and the synthetic challenges encountered in generating double-stapled (i, i + 4), (i, i + 3) constructs with the traditional S5 non-natural residue prompted us to develop optimized i, i + 3 stapling chemistry that replaced S5 with R3 at the N-terminal stapling position. This intervention led to facile production of singleand double-stapled MPER peptides incorporating i, i + 3 cross-links, with reaction conditions and yields matching those of traditional i, i + 4 stapling with S5 residues. Double-stapled constructs demonstrated nanomolar competitive binding affinity toward 4E10 and 10E8, with the best binder also manifesting 70-fold enhancement in proteolytic stability compared to the corresponding unstapled MPER peptide. This combination of structural stabilization and protease resistance afforded by hydrocarbon double-stapling may represent a highly desirable outcome for candidate immunogen development.
Structural analyses of SAH-MPER peptides in complex with 4E10 and 10E8 Fabs demonstrated the capacity of hydrocarbon stapling to recapitulate native antigenic peptide structures for two distinct broadly neutralizing anti-HIV-1 antibodies while preserving the critical peptide-binding interface by positioning the i, i + 3 cross-link on the noninteracting surface. The identification of an incorporated phosphate ion near the antigen-binding region of 4E10 revealed a potential phospholipid-binding site. Crystal structures of another broadly neutralizing anti-HIV-1 antibody, 2F5, in complex with the MPER domain identified a putative anionic lipid-binding site, on the basis of incorporation of a sulfate ion at the base of the CDR-H3 loop at high sulfate concentrations 57 . The binding mode and affinity by which diverse broadly neutralizing antibodies engage the lipid membrane may have important implications for candidate immunogen design and efficacy, and immunologic side effects 38, 39, 43, 57 . By incorporating a phosphate tether into the SAH-MPER design, we effectively accessed the identified phosphate-binding region on 4E10. Indeed, as structured templates, hydrocarbon-stapled peptides are amenable to derivatization to incorporate ancillary antibody-binding determinants, and they also reinforce unique architectures, such as the helix-kink-helix MPER motif. Thus, hydrocarbon stapling may serve as a useful addition to the arsenal of approaches aimed at fashioning just the right peptidic structure to elicit broadly neutralizing antibodies for HIV-1 and perhaps other vaccine targets.
METHODS
Methods and any associated references are available in the online version of the paper.
